• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Sept. 23

    Beckman Coulter Helping Labs Comply With Annex 1 Regulation

    FDA Clears MeMed BV Direct From Whole Blood

    Biostrap Debuts Tool to Measure Stress Resilience, Heart Rate Variability

    EndoTheia Announces Positive Study Results for Endoscopic Surgery Device
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Medtech’s Most Powerful M&A Drivers

    The Link Between Medtech and Connected Medical Devices

    Is the FTC Partly Responsible for Muted M&A Activity?

    Holistic Risk Management: Navigating the Future’s Uncertainties

    Defining End of Life for Medical Devices
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    Medbio LLC

    NDH Medical Inc.

    Johari Digital Healthcare Ltd.

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    Medbio LLC

    NDH Medical Inc.

    Johari Digital Healthcare Ltd.

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Robocath Secures 40 Million Euros Series C Financing

    Funding will help company deploy its operations development plan.

    Robocath Secures 40 Million Euros Series C Financing
    Robocath06.29.20
    Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, has secured 40 million euros ($43 million) in a series C round of financing. This was led by MicroPort Scientific Corporation, a major listed industrial player in the cardiovascular field, with participation from institutional investors (Zhejiang Silk Road Fund, Luxembourg CLIIF managed under TUS-Holdings, CS Group, and Anaxago) as well as existing Robocath investors.1

    The financial payment of 40million euros will enable the company to aggressively expand its sales and marketing efforts for its first robotic-assisted platform, R-One. It will also allow the company to broaden and accelerate the product development of its second-generation robot to address more PCI procedures and start peripheral and neurovascular applications.

    “We believe that the future growth of medical device therapies will be driven by innovative robotics platform technologies to facilitate procedures and open up next generation capabilities such as remote and AI,” said Dr. Alex He, general manager of Medbot (MicroPort’s robotics subsidiary). “We are thrilled to partner with Robocath to commercialize its highly innovative proprietary vascular robotics platform in the Chinese market.”

    On completion of this operation, existing Robocath investors,1 as well as Philippe Bencteux, chairman and founder of the company, will hold more than two thirds of the company’s capital.

    R-One is the first solution developed by Robocath. It uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. This medical procedure consists of revascularizing the cardiac muscle by inserting one or more implants (stents) into the arteries that supply it with blood. Every 30 seconds, somewhere in the world, this type of procedure is performed.

    R-One is designed to operate with precision and perform specific movements, creating better interventional conditions. Thanks to its open architecture, R-One is compatible with market-leading devices and cath labs.

    In a prospective, randomized, controlled pre-clinical trial, R-One demonstrated safety and efficacy as it achieved 100 percent technical procedure success and no MACE (Major adverse cardiovascular events). R-One received the CE marking in February 2019 and started its clinical application in September 2019. Currently R-One is available in Europe and Africa.

    Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all.

    In connection with this investment, Robocath and MicroPort have also signed a strategic agreement to set up a China-based joint-venture company. With more than 7,000 global employees, MicroPort has an established expertise in medical devices manufacturing and commercialization dating back to its founding in 1998 and is a leader in its domestic Chinese market in the cardiovascular field. The company has a full line of stents and balloons products worldwide and generated revenue of $793 million (729.5 million euros) in 2019 (approximately one third from its cardiovascular business). Over the last five years, the company had an average turnover growth of 17 percent. MicroPort has been listed on the Hong-Kong Stock Exchange Market since September 2010.

    “This financial round gives Robocath the resources to achieve its overall ambitions,” saidLucien Goffart, CEO of Robocath. “MicroPort’s commitment demonstrates the relevance of our value proposition. Thanks to the excellent technological and commercial synergies between our companies, we will accelerate our development and together build a great future in the vascular robotic field. This will benefit patients, physicians and ultimately healthcare systems.”

    Capitalizing on this shared expertise and through this joint-venture, Robocath will open the Asian market with the commercialization of its first robotic-assisted platform. This expansion will be facilitated by local manufacturing of consumables and robot’s assembly to ensure optimal distribution of Robocath products in this market. Both companies will also carry out research and development activities related to next generation long-distance, remote control over 5G network technologies and will develop artificial intelligence algorithms to be used with robotic-assisted platforms. 

    “With this financing round, Robocath enters a new phase in its strategic development. I am proud of how far we have come since the creation of the company and would like to thank all our historical shareholders for their renewed support and our new shareholders for their strong buy-in to our plans,” said Philippe Bencteux, chairman and founder of Robocath. “I’m delighted to welcome Mr. Jonathan Chen, chief international business officer at MicroPort, Dr. Alex He, general manager of Medbot, a MicroPort’s robotics subsidiary, and Mr. Haitong Wang, managing partner at Zhejiang Silk Road Fund, to our strategic committee.”

    For this operation, Robocath was advised by MAVIE Technologies and Bionest Partner Finance, fundraising advisors, and Dechert and L2B law offices.
     
    Reference
    1 GO CAPITAL, NCI, Cardio Participations, M Capital, Supernova Invest, Normandie Participations, Crédit Agricole Normandie, Unexo, Caisse d’Epargne Normandie
     
    Suggested For You
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Babson Diagnostics Raises $31 Million in Series B Funding Babson Diagnostics Raises $31 Million in Series B Funding
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    RapidPulse Closes $15 Million Series A Financing RapidPulse Closes $15 Million Series A Financing
    Quanta Raises $245 Million in Series D Funding Round Quanta Raises $245 Million in Series D Funding Round
    Baxter to Acquire Hillrom in $10.5 Billion Deal Baxter to Acquire Hillrom in $10.5 Billion Deal
    Hello Heart Raises $45M to Expand Digital Heart Health Platform Hello Heart Raises $45M to Expand Digital Heart Health Platform
    Tissium Appoints Romain Attard as CFO Tissium Appoints Romain Attard as CFO
    Robocath Completes First Robotic Coronary Angioplasties in Belgium Robocath Completes First Robotic Coronary Angioplasties in Belgium
    OnLume Surgical Completes $7 Million Series A Financing OnLume Surgical Completes $7 Million Series A Financing
    Pear Therapeutics to Become Public Company Pear Therapeutics to Become Public Company
    PPD, Science 37 Partner to Advance Decentralized Clinical Trials PPD, Science 37 Partner to Advance Decentralized Clinical Trials
    CeQur Raises $115 Million Series C5 Financing CeQur Raises $115 Million Series C5 Financing
    STERIS Completes $4.6B Deal for Cantel Medical STERIS Completes $4.6B Deal for Cantel Medical

    Related Breaking News

    • Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech

      Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech

      Electroducer Sleeve based on a medical technique called Direct Wire Pacing, which was invented by the company’s founder.
      Electroducer 09.21.21

    • Diagnostics
      Babson Diagnostics Raises $31 Million in Series B Funding

      Babson Diagnostics Raises $31 Million in Series B Funding

      Money will be used to help drive commercialization of customer-first, highly accessible diagnostic blood testing.
      Business Wire 09.20.21

    • Indago Announces $10 Million Financing Close and Name Change

      Indago Announces $10 Million Financing Close and Name Change

      Lazurite Holdings is developing technology to create the operating room of the future.
      Business Wire 09.15.21


    • Vertigo Treatment Receives FDA Breakthrough Device Designation

      Vertigo Treatment Receives FDA Breakthrough Device Designation

      The device's developer—Otolith Labs—closes $3.3 million in seed financing.
      Business Wire 09.13.21

    • RapidPulse Closes $15 Million Series A Financing

      RapidPulse Closes $15 Million Series A Financing

      Two industry veterans join the team to support the development of a cyclic aspiration system for ischemic stroke.
      Globe Newswire 09.10.21

    Loading, Please Wait..

    Trending
    • A New Approach To Post-Market Surveillance
    • Medtronic Obtains EU Nod For Simplera CGM
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • SteriTek Opens New E-Beam/X-Ray Sterilization Facility Near Dallas
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • MPO's Most-Read Stories This Week—Sept. 23
    • Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    • FDA Clears MeMed BV Direct From Whole Blood
    • Biostrap Debuts Tool to Measure Stress Resilience, Heart Rate Variability
    • EndoTheia Announces Positive Study Results for Endoscopic Surgery Device
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Releases Sustainability Report for Omega-3s Industry
    ABC’s Journal HerbalGram Celebrates 40th Anniversary
    Curcumin May Be As Effective as PPI for Indigestion
    Coatings World

    Latest Breaking News From Coatings World

    ACS Reports Chameleon Inspired Building Coating
    Substrate Wetting Agent Available from BRB International
    Nouryon Manufacturing Network Transitions to 100% Electricity From Renewable Sources in Brazil
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 23
    Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    FDA Clears MeMed BV Direct From Whole Blood
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Eftilagimod Cleared for Clinical Trial Use in the UK
    Veranova Names William Sanders Global VP of Chemical Development Ops
    Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Hailey Bieber's Rhode Expands Into Makeup
    Avon Enters Retail Partnership with Superdrug
    IT Award Winners Announced at MakeUp in NY
    Happi

    Latest Breaking News From Happi

    Jared Leto Ends Skin Care Line Twentynine Palms
    Ideal Image Offers FDA-Approved Alternative to Botox
    Nulastin Unveils Hair Growth Outcomes from Pair of Studies
    Ink World

    Latest Breaking News From Ink World

    Cooper Watson Acquires Tower Products
    The Durst Group Awarded Eight 2023 PRINTING United Alliance Pinnacle Awards
    Weekly Recap: Wikoff Color, HP, INX VC Top This Week’s Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PRX Market debuts, Tower Products acquired and more
    Flexo Wash to exhibit at FTA Fall Technical Conference
    Recyclable, deinkable stand-up pouch wins Gold in Germany
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Soft N' Dry Seeks to Expand Private Label Roll Out, Albis Completes Work on Line
    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Completes Work On Extra Wide Carding, Blending Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 23
    Anika Releases RevoMotion Reverse Shoulder Arthroplasty System
    Exactech's Activit-E Polyethylene OK'ed for Vantage Total Ankle
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    HID to Showcase Future-Proof Solutions at GITEX 2023
    Weekly Recap: Mergers and Acquisitions, IEC’s IME Standards Top This Week’s Stories
    EU-Funded Collaboration Hub Aims to Mainstream Printed Electronics

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login